Literature DB >> 2746732

Interplay between carbohydrate in the stalk and the length of the connecting peptide determines the cleavability of influenza virus hemagglutinin.

Y Kawaoka1, R G Webster.   

Abstract

The ability of many viruses to replicate in host cells depends on cleavage of certain viral glycoproteins, including hemagglutinin (HA). By generating site-specific mutant HAs of two highly virulent influenza viruses, we established that the relationship between carbohydrate in the stalk and the length of the connecting peptide is a critical determinant of cleavability. HAs that lacked an oligosaccharide side chain in the stalk were cleaved regardless of the number of basic amino acids at the cleavage site, whereas those with the oligosaccharide side chain resisted cleavage unless additional basic amino acids were inserted. This finding suggests that the oligosaccharide side chain interferes with HA cleavage if the number of basic amino acids at the cleavage site is not adequate to nullify this effect. Similar interplay could influence cleavage of other viral glycoproteins, such as those of human and simian immunodeficiency viruses and paramyxoviruses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2746732      PMCID: PMC250901     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide.

Authors:  R G Paterson; M A Shaughnessy; R A Lamb
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

2.  Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2).

Authors:  M Ohuchi; M Orlich; R Ohuchi; B E Simpson; W Garten; H D Klenk; R Rott
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

3.  The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses.

Authors:  F X Bosch; M Orlich; H D Klenk; R Rott
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

4.  Primary structural requirements for the enzymatic formation of the N-glycosidic bond in glycoproteins. Studies with alpha-lactalbumin.

Authors:  D K Struck; W J Lennarz; K Brew
Journal:  J Biol Chem       Date:  1978-08-25       Impact factor: 5.157

5.  Bacteria mature preproinsulin to proinsulin.

Authors:  K Talmadge; J Kaufman; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

6.  Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins.

Authors:  H Garoff; A M Frischauf; K Simons; H Lehrach; H Delius
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

7.  Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins.

Authors:  C M Rice; J H Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related.

Authors:  A L Hiti; A R Davis; D P Nayak
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

9.  Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus.

Authors:  M J Gething; J Bye; J Skehel; M Waterfield
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

10.  Complete nucleotide sequence of an influenza virus haemagglutinin gene from cloned DNA.

Authors:  A G Porter; C Barber; N H Carey; R A Hallewell; G Threlfall; J S Emtage
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

View more
  37 in total

Review 1.  Viral glycoprotein heterogeneity-enhancement of functional diversity.

Authors:  I T Schulze; I D Manger
Journal:  Glycoconj J       Date:  1992-04       Impact factor: 2.916

2.  A novel eight amino acid insertion contributes to the hemagglutinin cleavability and the virulence of a highly pathogenic avian influenza A (H7N3) virus in mice.

Authors:  Xiangjie Sun; Jessica A Belser; Terrence M Tumpey
Journal:  Virology       Date:  2015-11-26       Impact factor: 3.616

3.  Characterization of an H4N2 influenza virus from Quails with a multibasic motif in the hemagglutinin cleavage site.

Authors:  Sook-San Wong; Sun-Woo Yoon; Mark Zanin; Min-Suk Song; Christine Oshansky; Hassan Zaraket; Stephanie Sonnberg; Adam Rubrum; Patrick Seiler; Angela Ferguson; Scott Krauss; Carol Cardona; Richard J Webby; Beate Crossley
Journal:  Virology       Date:  2014-08-23       Impact factor: 3.616

Review 4.  The enzymology of proinsulin conversion.

Authors:  J C Hutton; C J Rhodes
Journal:  Cell Biophys       Date:  1991 Oct-Dec

5.  Role of conserved glycosylation sites in maturation and transport of influenza A virus hemagglutinin.

Authors:  P C Roberts; W Garten; H D Klenk
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Virus Res       Date:  2013-03-14       Impact factor: 3.303

7.  Structural features influencing hemagglutinin cleavability in a human influenza A virus.

Authors:  Y Kawaoka
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Sequence of an influenza virus hemagglutinin determined directly from a clinical sample.

Authors:  A Rajakumar; E M Swierkosz; I T Schulze
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  Antigenic determinants of measles virus hemagglutinin associated with neurovirulence.

Authors:  U G Liebert; S G Flanagan; S Löffler; K Baczko; V ter Meulen; B K Rima
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).

Authors:  Bin Su; Sébastien Wurtzer; Marie-Anne Rameix-Welti; Dominic Dwyer; Sylvie van der Werf; Nadia Naffakh; François Clavel; Béatrice Labrosse
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.